A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology
暂无分享,去创建一个
Beatrice Aramini | Massimo Dominici | Elisabetta Manuela Foppiani | Olivia Candini | Valentina Masciale | P. Conte | M. Dominici | G. Grisendi | V. Masciale | B. Aramini | O. Candini | T. Petrachi | C. Spano | Giulia Grisendi | Carlotta Spano | Pierfranco Conte | Matteo Brogli | Tiziana Petrachi | Elena Veronesi | Giorgio Mari | Elena Veronesi | Giorgio Mari | Matteo Brogli | E. Foppiani | Tiziana Petrachi
[1] Ivan Martin,et al. Three‐dimensional culture of melanoma cells profoundly affects gene expression profile: A high density oligonucleotide array study , 2005, Journal of cellular physiology.
[2] C. Ries,et al. Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab , 2009, Oncogene.
[3] C. Hendriksen,et al. Reduction Strategies in Animal Research: A Review of Scientific Approaches at the Intra-experimental, Supra-experimental and Extra-experimental Levels , 2005, Alternatives to laboratory animals : ATLA.
[4] Li-Hsin Han,et al. Modeling Physiological Events in 2D vs. 3D Cell Culture. , 2017, Physiology.
[5] N. Baldini,et al. Mesenchymal Progenitors Expressing TRAIL Induce Apoptosis in Sarcomas , 2015, Stem cells.
[6] G. Borchard,et al. In vitro models for immunogenicity prediction of therapeutic proteins , 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[7] Laurent Ségalat,et al. High‐throughput screening and small animal models, where are we? , 2010, British journal of pharmacology.
[8] J. Kassis,et al. 3D in vitro tissue models and their potential for drug screening , 2013, Expert opinion on drug discovery.
[9] Madeline A. Lancaster,et al. Cerebral organoids model human brain development and microcephaly , 2013, Nature.
[10] Tobias Schmelzle,et al. Engineering tumors with 3D scaffolds , 2007, Nature Methods.
[11] Mark J. Smyth,et al. The TRAIL apoptotic pathway in cancer onset, progression and therapy , 2008, Nature Reviews Cancer.
[12] Marc Bickle,et al. Screening out irrelevant cell-based models of disease , 2016, Nature Reviews Drug Discovery.
[13] S. Sahoo,et al. 3-D tumor model for in vitro evaluation of anticancer drugs. , 2008, Molecular pharmaceutics.
[14] A. Knight. Systematic reviews of animal experiments demonstrate poor contributions toward human healthcare. , 2008, Reviews on recent clinical trials.
[15] Francesco Pampaloni,et al. Three-Dimensional Cell Cultures in Toxicology , 2009, Biotechnology & genetic engineering reviews.
[16] K. Lamperska,et al. 2D and 3D cell cultures – a comparison of different types of cancer cell cultures , 2016, Archives of medical science : AMS.
[17] Y. Hérault,et al. Generation and Use of Transgenic Mice in Drug Discovery , 2014 .
[18] K. Wanner,et al. Methods and Principles in Medicinal Chemistry , 2007 .
[19] Kinam Park,et al. Development of an in vitro 3D tumor model to study therapeutic efficiency of an anticancer drug. , 2013, Molecular pharmaceutics.
[20] Brendon M. Baker,et al. Deconstructing the third dimension – how 3D culture microenvironments alter cellular cues , 2012, Journal of Cell Science.
[21] Maddaly Ravi,et al. 3D Cell Culture Systems: Advantages and Applications , 2015, Journal of cellular physiology.
[22] Chi-Ping Day,et al. Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges , 2015, Cell.
[23] Darren Finlay,et al. 3-Dimensional Culture Systems for Anti-Cancer Compound Profiling and High-Throughput Screening Reveal Increases in EGFR Inhibitor-Mediated Cytotoxicity Compared to Monolayer Culture Systems , 2014, PloS one.
[24] A. Maiorana,et al. Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer , 2019, Scientific Reports.
[25] P Smith,et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. , 2000, Regulatory toxicology and pharmacology : RTP.
[26] L. Romero,et al. Alternative Models in Drug Discovery and Development Part II: In Vivo Nonmammalian and Exploratory/Experimental Human Models , 2014 .
[27] L. Romero,et al. Alternative Models in Drug Discovery and Development Part I: In Silico and In Vitro Models , 2014 .
[28] J. Wargo,et al. Hallmarks of response to immune checkpoint blockade , 2017, British Journal of Cancer.
[29] W. Luyten,et al. Three‐dimensional cell culture models for anticancer drug screening: Worth the effort? , 2018, Journal of cellular physiology.
[30] Kathleen A Fitzgerald,et al. Life in 3D is never flat: 3D models to optimise drug delivery. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[31] E. A. Elsayed,et al. In Vitro and In Vivo Anti-Breast Cancer Activities of Some Synthesized Pyrazolinyl-estran-17-one Candidates , 2018, Molecules.
[32] Georges Noel,et al. Three-Dimensional Cell Culture: A Breakthrough in Vivo , 2015, International journal of molecular sciences.